Article

Full Access

Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats

Corresponding Author

David D. Thompson Ph.D.

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Department of Bone Biology and Osteoporosis Research, W26A-1000, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486Search for more papers by this author

J. Gregory Seedor,

J. Gregory Seedor

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Miron Weinreb,

Miron Weinreb

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Gideon A. Rodan,

Gideon A. Rodan

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Sergio Rosini,

Sergio Rosini

Instituto Gentili Spa, Pisa, Italy

Search for more papers by this author

David D. Thompson Ph.D.,

Corresponding Author

David D. Thompson Ph.D.

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Department of Bone Biology and Osteoporosis Research, W26A-1000, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486Search for more papers by this author

J. Gregory Seedor,

J. Gregory Seedor

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Miron Weinreb,

Miron Weinreb

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Gideon A. Rodan,

Gideon A. Rodan

Department of Bone Biology/Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486

Search for more papers by this author

Sergio Rosini,

Sergio Rosini

Instituto Gentili Spa, Pisa, Italy

Search for more papers by this author

First published: March 1990

https://doi.org/10.1002/jbmr.5650050312

Citations: 72

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Abstract

The purpose of this study was to document the effects of aminobutane bisphosphonate (AHBuP) on bone remodeling during immobilization in rats.

Male Sprague-Dawley rats underwent unilateral sciatic neurectomy after receiving two daily subcutaneous injections of 0, 0.01, 0.10, or 1.0 mg P per kg AHBuP. Rats were sacrificed at 24 h or 10 or 20 days postimmobilization. Femora were ashed and tibiae were prepared for histomorphometric analysis.

AHBuP was effective in inhibiting bone loss due to immobilization in a dose-dependent manner. The percentage loss of femoral ash weight due to immobilization decreased in a dose-dependent manner. In vehicle-treated rats, there was a significant decrease in trabecular bone volume (TBV) in the immobilized tibiae compared to the normal tibiae; in AHBuP-treated rats there was a dose-dependent increase in TBV both in the immobilized and control tibiae. The osteoid surface extent was decreased in AHBuP-treated rats in a dose-dependent manner. The mineral apposition rate was altered only in the intact leg of rats treated with 0.1 and 1.0 mg P AHBuP per kg compared to vehicle treated. Osteoclast number per mm was reduced by AHBuP treatment.

In conclusion, aminohydroxybutane bisphosphonate effectively prevented the bone loss due to immobilization in this system.

References

1 Weinreb M, Rodan GA, Thompson DD 1989 Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. Bone 10 (3): 187–194.
10.1016/8756-3282(89)90052-5
CAS PubMed Web of Science® Google Scholar
2 Turner RT, Bell NH 1986 The effects of immobilization on bone histomorphometry in rats. J Bone Min Res 1 (5): 339–407.
PubMed Google Scholar
3 Orimo H, Fujita T, Yoshikawa M 1971 Effect of calcitonin on the development of immobilization osteoporosis in rat. Endocrinol Jpn 18 (1): 117–121.
Google Scholar
4 Kenny AD 1985 Role of carbonic anhydrase in bone: Plasma acetazolamide concentrations associated with inhibition of bone loss. Pharmacology 31: 97–107.
10.1159/000138104
CAS PubMed Web of Science® Google Scholar
5 Thompson DD, Rodan GA 1988 Indomethacin inhibition of tenotomy-induced bone resorption in rats. J Bone Min Res 3 (4): 409–414.
10.1002/jbmr.5650030407
CAS PubMed Web of Science® Google Scholar
6 Fleisch H, Russell RGG, Simpson B, Muhlbauer RC 1969 Prevention by a diphosphonate of immobilization “osteoporosis” in rats. Nature 223: 211–212.
10.1038/223211a0
CAS PubMed Web of Science® Google Scholar
7 Michael WR, King WR, Francis MD 1971 Effectiveness of diphosphonates in preventing osteoporosis of disuse in the rat. Clin Orthop Relat Res 78: 271–276.
10.1097/00003086-197107000-00022
PubMed Google Scholar
8 Minaire PJ, Depasso J, Berard E, Meunier PJ, Edouard C, Gilonchery G, Goedert G 1987 Effects of clodronate on immobilization bone loss. Bone 8 (Suppl. 1): S63–S68.
PubMed Web of Science® Google Scholar
9 Schoulens A, Verhas M, Dourou N, Bergmann P, Caulen F, Verschaeres A, Mone M, Heilporn A 1988 Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate and indomethacin. Calcif Tissue Int 42: 136–143.
Google Scholar
10 Fleisch H 1983 Bisphosphonates: Mechanism of action and clinical applications. In: WA Peck (ed) Bone and Mineral Research, Annual 11. Excerpta Medica, Amsterdam, pp. 319–357.
Google Scholar
11 Schenk R, Eggli P, Fleisch H, Rosini S 1986 Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38: 342–349.
10.1007/BF02555748
CAS PubMed Web of Science® Google Scholar
12 Adami S, Salvagno G, Guarrera G, Montesantei F, Garavelli G, Rosini S, LoCascio V 1986 Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate. Calcif Tissue Int 39: 226–229.
10.1007/BF02555208
CAS PubMed Web of Science® Google Scholar
13 Kozak S, Rizzoli R, Trechsel U, Fleisch H 1987 Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinoma 256/B in thyroparathyroidectomized rats. Cancer Res 47: 6193–6197.
CAS PubMed Web of Science® Google Scholar
14 Adami S, Bolzicco GP, Rizzo A, Solvagno G, Bertoldo F, Rosini M, Suppi R, LoCascio V 1987 The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy. Bone Min 2: 395–404.
PubMed Web of Science® Google Scholar
15 Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJH, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Min Res 2 (6): 595–610.
10.1002/jbmr.5650020617
CAS PubMed Web of Science® Google Scholar
16 Schenk R, Merz WA, Muhlbauer R, Russell RGG, Fleisch H 1973 Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl₂MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11: 196–214.
10.1007/BF02547219
CAS PubMed Web of Science® Google Scholar
17 Marie PJ, Hott M, Garba M-T 1985 Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (A PrBP) in the mouse. Bone 6: 193–200.
10.1016/8756-3282(85)90053-5
CAS PubMed Web of Science® Google Scholar
18 Wolff J 1892 Des Gesetz der Transformation der Knochen. A. Hirschwald, Berlin.
Google Scholar

Citing Literature

Volume5, Issue3

March 1990

Pages 279-286

Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats

Abstract

References

Citing Literature

References

Related

Information